• Have a question?
    Open from 8am to 7pm Monday to Friday    Call customer services
    0345 54 32 600


| Print

Dr. Reddy's Laboratories Ltd (RDY)

ADS Common
Sell: $12.06|Buy: $12.41|Change: 0.07 (0.58%)

This share can be held in a Dealing accountSIPP

Company profile

Dr. Reddy's is one of the largest generic drug manufacturers in the world. It has a significant presence in North America, a region that makes up roughly 40% of its generics sales, with other key markets being India (20%) and Europe (20%).Beyond simple generics, Dr. Reddy's also has a solid portfolio of injectables which make up 25% of its North America sales. In branded generic markets like India, Dr. Reddy's has established a compelling presence with its strong brand nameand earned a top five spot in key therapeutic areas including oncology and gastroenterology. Dr. Reddy's also has an active pharmaceutical ingredient business that manufactures over 150 APIs and sells in over 75 countries.

Address

8-2-337, Road No. 3
Banjara Hills
Hyderabad
Telangana
IND
500034

Telephone

+91 40 49002900

Website

https://www.drreddys.com

Sector 

Healthcare

Forecast key dates

NameKey Date
Dr Reddy's Laboratories Ltd Annual General Meeting for 20272027-07-23T11:00:00
Dr Reddy's Laboratories Ltd First Quarter Earnings Conference Call for 20282027-07-22T19:30:00
Dr Reddy's Laboratories Ltd First Quarter Earnings Results for 20282027-07-22T00:00:00
Dr Reddy's Laboratories Ltd Annual Report for 20272027-05-28T00:00:00
Dr Reddy's Laboratories Ltd Fourth Quarter Earnings Conference Call for 20272027-05-12T10:00:00
Dr Reddy's Laboratories Ltd Fourth Quarter Earnings Results for 20272027-05-12T00:00:00
Dr Reddy's Laboratories Ltd Third Quarter Earnings Conference Call for 20272027-01-21T19:30:00
Dr Reddy's Laboratories Ltd Third Quarter Earnings Results for 20272027-01-21T00:00:00
Dr Reddy's Laboratories Ltd Second Quarter Earnings Conference Call for 20272026-10-23T19:30:00
Dr Reddy's Laboratories Ltd Second Quarter Earnings Results for 20272026-10-23T00:00:00

Previous key dates

NameKey Date
Dr Reddy's Laboratories Ltd Annual General Meeting for 20262026-07-23T11:00:00
Dr Reddy's Laboratories Ltd First Quarter Earnings Conference Call for 20272026-07-22T19:30:00
Dr Reddy's Laboratories Ltd First Quarter Earnings Result for 20272026-07-22T00:00:00
Dr Reddy's Laboratories Ltd Annual Report for 20262026-05-29T00:00:00
Dr Reddy's Laboratories Ltd Fourth Quarter Earnings Conference Call for 20262026-05-12T10:00:00
Dr Reddy's Laboratories Ltd Fourth Quarter Earnings Result for 20262026-05-12T00:00:00
Dr Reddy's Laboratories Ltd Third Quarter Earnings Conference Call for 20262026-01-21T19:30:00
Dr Reddy's Laboratories Ltd Third Quarter Earnings Result for 20262026-01-21T00:00:00
Dr Reddy's Laboratories Ltd Second Quarter Earnings Conference Call for 20262025-10-24T19:30:00
Dr Reddy's Laboratories Ltd Second Quarter Earnings Result for 20262025-10-24T00:00:00

AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.

© Copyright 2026 AJ Bell. All rights reserved.